Skip to search boxSkip to navigationSkip to main content

Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes

  • Mohammed Abdelsaid
    ,
  • Roshini Prakash
    ,
  • Weiguo Li
    ,
  • Maha Coucha
    ,
  • Sherif Hafez
    ,
  • Maribeth H. Johnson
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>Diabetes impedes vascular repair and causes vasoregression in the brain after stroke, but mechanisms underlying this response are still unclear. We hypothesized that excess peroxynitrite formation in diabetic ischemia/reperfusion (I/R) injury inactivates the p85 subunit of phosphoinositide 3-kinase (PI3K) by nitration and diverts the PI3K-Akt survival signal to the p38- mitogen- Activated protein kinase apoptosis pathway. Nitrotyrosine (NY), Akt and p38 activity, p85 nitration, and caspase-3 cleavage were measured in brains from control, diabetic (GK), or metformin- Treated GK rats subjected to sham or stroke surgery and in brain microvascular endothelial cells (BMVECs) from Wistar and GK rats subjected to hypoxia/reoxygenation injury. GK rat brains showed increased NY, caspase-3 cleavage, and p38 activation and decreased Akt activation. Metformin attenuated stroke-induced nitrative signaling in GK rats. GK rat BMVECs showed increased basal nitrative stress compared with controls. A second hit by hypoxia/reoxygenation injury dramatically increased the nitration of p85 and activation of p38 but decreased Akt. These effects were associated with impairment of angiogenic response and were restored by treatment with the peroxynitrite scavenger 5,10,15,20- Tetrakis(4- sulfonatophenyl)porphyrinato iron III chloride or the nitration inhibitor epicatechin. Our results provide evidence that I/R-induced peroxynitrite inhibits survival, induces apoptosis, and promotes peroxynitrite as a novel therapeutic target for the improvement of reparative angiogenesis after stroke in diabetes.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1804-1817 (14 pages)

Journal (Volume, Issue Number)

Diabetes (Volume 64, Issue 5)

Publication milestones

  • Published - 05/2015

Publication status

Published - 05/2015

ISSN

0012-1797

Publication IDs

  • Scopus: 84981508397
  • PubMed: 25524911

Publication metrics

Metrics

Fractional count
3
Fractional count
0.38
Fractional count
5
Fractional count
0.63
Fractional count
3
Fractional count
1
SciVal
FWCI
2.83
SciVal
Author count
8
SciVal
citations
49
SciVal
Paper percentile
95
SciVal
Top percentile
5
Scopus
citations

PlumX, opens in new tab

Captures
62
Citation count
65

Funding Details

Funding. This work was supported in part by an American Heart Association Postdoctoral Fellowship (14POST19580004 to M.A.); American Heart Association Predoctoral Fellowships (12PRE11300001 to M.C. and 13PRE17090026 to S.H.); Veterans Affairs Merit Awards (BX000347, BX00891) and National Institutes of Health award (NS-063965) to S.C.F.; and a Veterans Affairs Research Career Scientists award and National Institutes of Health awards (NS-070239, NS-083559) to A.E. A.E. is a Research Career Scientist at the Charlie Norwood Veterans Administration Medical Center in Augusta, GA. Duality of Interest. No potential conflicts of interest relevant to this article were reported. Author Contributions. M.A. collected and analyzed the data and wrote the manuscript. R.P. and W.L. collected the data. M.C. and S.H. collected and analyzed the data. M.H.J. performed statistical analyses and reviewed the manuscript. S.C.F. reviewed the manuscript. A.E. wrote and reviewed the manuscript. A.E. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. This work was supported in part by an American Heart Association Postdoctoral Fellowship (14POST19580004 to M.A.); American Heart Association Predoctoral Fellowships (12PRE11300001 to M.C. and 13PRE17090026 to S.H.); Veterans Affairs Merit Awards (BX000347, BX00891) and National Institutes of Health award (NS-063965) to S.C.F.; and a Veterans Affairs Research Career Scientists award and National Institutes of Health awards (NS-070239, NS- 083559) to A.E. A.E. is a Research Career Scientist at the Charlie Norwood Veterans Administration Medical Center in Augusta, GA.
FundersFunding numbers
Charlie Norwood Veterans Administration Medical Center
-
Current affiliations: Divisions of Gastroenterology (J.C.M., S.H., A.M.C., R.B., M.A., L.R.L., K.J.V
-
S.C.F.
-
Administration Medical Center
-
Veterans Affairs Research Development Award
NS-070239, NS-083559
NIH
NS-063965
FNIH
-
VA
I01BX000891
AHA
12PRE11300001, 14POST19580004, 13PRE17090026
NOVA
BX000347, BX00891